Cita APA

Ruiz de Porras, V., Bystrup, S., Cabrero de las Heras, S., Musulén, E., Palomero, L., Alonso Aguado, M. H., . . . Martínez Balibrea, E. (2019). Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.

Citación estilo Chicago

Ruiz de Porras, Vicenç, et al. Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients. 2019.

Cita MLA

Ruiz de Porras, Vicenç, et al. Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients. 2019.